Literature DB >> 29313227

Apolipoprotein A-I Stimulates Cell Proliferation in Bone Marrow Cell Culture.

I F Usynin1, A N Dudarev2, A Yu Gorodetskaya2, S M Miroshnichenko2, T A Tkachenko, V I Tkachenko2.   

Abstract

Culturing of bone marrow cells in serum-free RPMI-1640 medium led to a decrease in the rate of DNA biosynthesis. Addition of HDL or their main protein component apolipoprotein A-I to the culture medium dose-dependently increased the rate of [3H]-thymidine incorporation into DNA. The maximum stimulation was achieved at HDL concentration of 80 μg/ml and apolipoprotein A-I concentration of 20 μg/ml. To identify the target-cells of apolipoprotein A-I, we used thymidine analogue 5-ethynyl-2'-deoxyuridine (EdU) that incorporates into cell DNA at the stage of replicative DNA synthesis (S phase) and can be detected by fluorescence microscopy. In bone marrow cell culture, apolipoprotein A-I stimulates the proliferation of monocyte (monoblasts, promonocytes) and granulocyte (myeloblasts, promyelocytes) progenitor cells, as well as bone marrow stromal cells.

Entities:  

Keywords:  DNA synthesis; apolipoprotein A-I; bone marrow; plasma lipoproteins; proliferation

Mesh:

Substances:

Year:  2018        PMID: 29313227     DOI: 10.1007/s10517-018-3978-0

Source DB:  PubMed          Journal:  Bull Exp Biol Med        ISSN: 0007-4888            Impact factor:   0.804


  4 in total

1.  A modular approach toward producing nanotherapeutics targeting the innate immune system.

Authors:  Mandy M T van Leent; Anu E Meerwaldt; Alexandre Berchouchi; Yohana C Toner; Marianne E Burnett; Emma D Klein; Anna Vera D Verschuur; Sheqouia A Nauta; Jazz Munitz; Geoffrey Prévot; Esther M van Leeuwen; Farideh Ordikhani; Vera P Mourits; Claudia Calcagno; Philip M Robson; George Soultanidis; Thomas Reiner; Rick R M Joosten; Heiner Friedrich; Joren C Madsen; Ewelina Kluza; Roy van der Meel; Leo A B Joosten; Mihai G Netea; Jordi Ochando; Zahi A Fayad; Carlos Pérez-Medina; Willem J M Mulder; Abraham J P Teunissen
Journal:  Sci Adv       Date:  2021-03-05       Impact factor: 14.957

2.  Apolipoprotein-A is a potential prognostic biomarker for severe aplastic anemia patients treated with ATG-based immunosuppressive therapy: a single-center retrospective study.

Authors:  Qi Liu; Huijie Dong; Yuzhu Li; Yingying Shen; Yilei Hong; Ying Chen; Shan Liu; Xiaolian Wu; Wenbin Liu; Huijin Hu; Yuechao Zhao; Shenyun Lin; Yiping Shen; Yuhong Zhou; Baodong Ye; Dijiong Wu
Journal:  Lipids Health Dis       Date:  2022-10-04       Impact factor: 4.315

3.  Apolipoprotein A-I Supports MSCs Survival under Stress Conditions.

Authors:  Svetlana Miroshnichenko; Ivan Usynin; Alexey Dudarev; Vadim Nimaev; Anastasiya Solovieva
Journal:  Int J Mol Sci       Date:  2020-06-05       Impact factor: 5.923

4.  Construction of Recombinant Human GM-CSF and GM-CSF-ApoA-I Fusion Protein and Evaluation of Their Biological Activity.

Authors:  Mariya Pykhtina; Svetlana Miroshnichenko; Vladimir Romanov; Antonina Grazhdantseva; Galina Kochneva; Anatoly Beklemishev
Journal:  Pharmaceuticals (Basel)       Date:  2021-05-13
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.